In an effort to expand its analytical testing capabilities, global healthcare company Sotera Health has acquired Gibraltar Laboratories.
acquisition
The acquisition is expected to expand the analytical testing capabilities of Sotera Health’s Nelson Labs business.
As a leading outsourced provider of microbiology and analytical chemistry testing, Gibraltar will add to Nelson Labs’ existing strengths in medical device microbiology and expert advisory services.
The acquisition will give Nelson Lab’s access to Gibraltar’s facilities which are FDA registered and ISO 17025 accredited, and which also have the distinction of being accredited for both the microbiological and chemical fields.
Gibraltar runs two laboratories in the New Jersey tri-state area and is known for USP compendial microbiology, sterility assurance and analytical chemistry testing.
CEO of Sotera Health, Michael B. Petras Jr, said: “This acquisition will expand our presence in this important region and further strengthen our testing capabilities for the pharmaceutical industry. We welcome Gibraltar’s strong management and expert staff as they join our mission of Safeguarding Global Health.”
Dr Daniel L. Prince, president of Gibraltar Laboratories, added: “Through the commitment of three generations of the Prince family, as well as our experienced staff of microbiology and chemistry professionals, we have earned a reputation as a reliable, responsive and highly professional partner for our customers, and we know we have found the same in Sotera Health. My goal is for Gibraltar to continue to build on its long-standing reputation of excellence and continue to expand its offerings. We accomplish this by becoming part of Sotera Health, a global company whose breadth of services and expansive reach provide extraordinary value to the industries we are proud to serve.”
“Gibraltar’s offerings and the strategic location of its facilities will be a great benefit to our mutual customers, who value working with a trusted partner that can consistently deliver quality, service and expertise,” said Jeff Nelson president of Nelson Labs.
“The Gibraltar team is known for these values and also has an excellent reputation for designing specialised studies that help manufacturers prove the safety, efficacy and regulatory compliance of their products. I am also personally excited to be working directly with Dr. Daniel Prince, who I consider a leading thinker in our field,” he added.